|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Stock-based compensation | |||||
| Depreciation | |||||
| ESOP compensation expense | |||||
| Deferred income tax benefit | |||||
| Loss on sale of property, plant and equipment | |||||
| Changes in assets and liabilities: | |||||
| Increase in trade accounts receivable | |||||
| Increase in income taxes receivable | |||||
| (Increase) Decrease in inventories | |||||
| Increase in prepaid expenses and other current assets | |||||
| Increase (Decrease) in accounts payable | |||||
| Increase in accrued salaries and wages | |||||
| (Decrease) Increase in vacation accrual | |||||
| Decrease other accrued expenses | |||||
| (Decrease) Increase in payroll and other taxes withheld | |||||
| Increase in contract liabilities | |||||
| (Decrease) Increase in income taxes payable | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Additions to property, plant and equipment | |||||
| Proceeds from grant award | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Purchase of investment securities | |||||
| Proceeds from sale/maturity of investment securities | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Dividends paid on common stock | |||||
| Proceeds from exercise of stock options | |||||
| Net cash (used in) provided by financing activities | |||||
| Increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of the year | |||||
| Cash and cash equivalents, end of the year | |||||
| Supplemental Schedule of Cash Flow Information: | |||||
| Income taxes paid, net of refunds | |||||
Loading...